Bank of America’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25B | Sell |
|
|||||
|
2025
Q1 | $1.39B | Buy |
|
|||||
|
2024
Q4 | $974M | Sell |
|
|||||
|
2024
Q3 | $1.21B | Buy |
|
|||||
|
2024
Q2 | $1.21B | Buy |
|
|||||
|
2024
Q1 | $1.06B | Buy |
|
|||||
|
2023
Q4 | $991M | Buy |
|
|||||
|
2023
Q3 | $818M | Buy |
|
|||||
|
2023
Q2 | $823M | Sell |
|
|||||
|
2023
Q1 | $815M | Buy |
|
|||||
|
2022
Q4 | $721M | Sell |
|
|||||
|
2022
Q3 | $732M | Sell |
|
|||||
|
2022
Q2 | $760M | Sell |
|
|||||
|
2022
Q1 | $814M | Buy |
|
|||||
|
2021
Q4 | $680M | Buy |
|
|||||
|
2021
Q3 | $550M | Buy |
|
|||||
|
2021
Q2 | $309M | Buy |
|
|||||
|
2021
Q1 | $315M | Buy |
|
|||||
|
2020
Q4 | $319M | Sell |
|
|||||
|
2020
Q3 | $401M | Buy |
|
|||||
|
2020
Q2 | $415M | Buy |
|
|||||
|
2020
Q1 | $322M | Buy |
|
|||||
|
2019
Q4 | $258M | Buy |
|
|||||
|
2019
Q3 | $148M | Sell |
|
|||||
|
2019
Q2 | $172M | Sell |
|
|||||
|
2019
Q1 | $199M | Sell |
|
|||||
|
2018
Q4 | $269M | Sell |
|
|||||
|
2018
Q3 | $353M | Buy |
|
|||||
|
2018
Q2 | $285M | Buy |
|
|||||
|
2018
Q1 | $267M | Buy |
|
|||||
|
2017
Q4 | $210M | Sell |
|
|||||
|
2017
Q3 | $231M | Buy |
|
|||||
|
2017
Q2 | $151M | Sell |
|
|||||
|
2017
Q1 | $144M | Sell |
|
|||||
|
2016
Q4 | $99M | Sell |
|
|||||
|
2016
Q3 | $121M | Sell |
|
|||||
|
2016
Q2 | $128M | Buy |
|
|||||
|
2016
Q1 | $117M | Sell |
|
|||||
|
2015
Q4 | $225M | Sell |
|
|||||
|
2015
Q3 | $205M | Buy |
|
|||||
|
2015
Q2 | $31M | Buy |
|
|||||
|
2015
Q1 | $29.1M | Buy |
|
|||||
|
2014
Q4 | $22.8M | Buy |
|
|||||
|
2014
Q3 | $18M | Sell |
|
|||||
|
2014
Q2 | $27.4M | Sell |
|
|||||
|
2014
Q1 | $34.5M | Buy |
|
|||||
|
2013
Q4 | $34.6M | Buy |
|
|||||
|
2013
Q3 | $24.1M | Sell |
|
|||||
|
2013
Q2 | $32.3M | Buy |
|